Steve Damment
Fondateur chez Aluztura Bio Ltd.
Postes actifs de Steve Damment
Sociétés | Poste | Début | Fin |
---|---|---|---|
Aluztura Bio Ltd. | Fondateur | 01/01/2014 | - |
Corporate Officer/Principal | 01/01/2014 | - |
Historique de carrière de Steve Damment
Anciens postes connus de Steve Damment
Sociétés | Poste | Début | Fin |
---|---|---|---|
BIODEXA PHARMACEUTICALS PLC | Directeur Technique/Scientifique/R&D | 01/06/2018 | 30/09/2021 |
Corporate Officer/Principal | 01/05/2015 | 01/06/2018 | |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | Corporate Officer/Principal | 01/01/2000 | 01/12/2013 |
GSK PLC | Corporate Officer/Principal | 01/07/1982 | 01/12/1999 |
Formation de Steve Damment
The University of Liverpool | Undergraduate Degree |
Statistiques
Internationale
Royaume-Uni | 6 |
Opérationnelle
Corporate Officer/Principal | 4 |
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sectorielle
Health Technology | 3 |
Commercial Services | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
GSK PLC | Health Technology |
BIODEXA PHARMACEUTICALS PLC | Health Technology |
Entreprise privées | 2 |
---|---|
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | Commercial Services |
Aluztura Bio Ltd. |
- Bourse
- Insiders
- Steve Damment
- Expérience